ssMutPA: single-sample mutation-based pathway analysis approach for cancer precision medicine
GigaScience · 2024
DOI: 10.1093/gigascience/giae105 ↗Kurz gefasst
Fachartikel in der Zeitschrift GigaScience, 2024. Verfasst von Yalan He und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Precision Medicine, Mutation, Neoplasms, Protein Interaction Maps. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Background
Single-sample pathway enrichment analysis is an effective approach for identifying cancer subtypes and pathway biomarkers, facilitating the development of precision medicine. However, the existing approaches focused on investigating the changes in gene expression levels but neglected somatic mutations, which play a crucial role in cancer development.
Findings
In this study, we proposed a novel single-sample mutation-based pathway analysis approach (ssMutPA) to infer individualized pathway activities by integrating somatic mutation data and the protein–protein interaction network. For each sample, ssMutPA first uses local and global weighted strategies to evaluate the effects of genes from mutations according to the network topology and then calculates a single-sample mutation-based pathway enrichment score (ssMutPES) to reflect the accumulated effect of mutations of each pathway. To illustrate the performance of ssMutPA, we applied it to 33 cancer cohorts from The Cancer Genome Atlas database and revealed patient stratification with significantly different prognosis in each cancer type based on the ssMutPES profiles. We also found that the identified characteristic pathways with high overlap across different cancers could be used as potential prognosis biomarkers. Moreover, we applied ssMutPA to 2 melanoma cohorts with immunotherapy and identified a subgroup of patients who may benefit from therapy.
Conclusions
We provided evidence that ssMutPA could infer mutation-based individualized pathway activity profiles and complement the current individualized pathway analysis approaches focused on gene expression data, which may offer the potential for the development of precision medicine. ssMutPA is available at https://CRAN.R-project.org/package=ssMutPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
ORCID-Profile: Yalan He, Jiyin Lai, Qian Wang, Bingyue Pan, Siyuan Li, Xilong Zhao, Ziyi Wang, Yongbao Zhang, Yujie Tang, Junwei Han
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
He, Y., Lai, J., Wang, Q., Pan, B., Li, S., Zhao, X., Wang, Z., Zhang, Y., Tang, Y., & Han, J. (2024). ssMutPA: single-sample mutation-based pathway analysis approach for cancer precision medicine. GigaScience. https://doi.org/10.1093/gigascience/giae105
Vancouver
He Y, Lai J, Wang Q, Pan B, Li S, Zhao X, et al. ssMutPA: single-sample mutation-based pathway analysis approach for cancer precision medicine. GigaScience. 2024. doi:10.1093/gigascience/giae105
BibTeX
@article{He2024,
author = {He, Yalan and Lai, Jiyin and Wang, Qian and Pan, Bingyue and Li, Siyuan and Zhao, Xilong and Wang, Ziyi and Zhang, Yongbao and Tang, Yujie and Han, Junwei},
title = {ssMutPA: single-sample mutation-based pathway analysis approach for cancer precision medicine},
journal = {GigaScience},
year = {2024},
doi = {10.1093/gigascience/giae105}
}
EUVIMED